발행물
컨퍼런스
The 46th Annual Meeting & Exposition of the Controlled Release Society (CRS)
2024
,
Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome, and immune responses in colitis.
Cancer Hematopoiesis and Immunology Program (CHI Seminar), Rogel Cancer Center, University of Michigan
2019
Hyaluronic acid-bilirubin nanoparticles for targeted modulation of dysregulated intestinal barrier, microbiome, and immune responses in colitis
Pharmaceutical Sciences Seminar, College of Pharmacy, University of Michigan
2018
The 1st KAST-KSSEA Young Generation Scientist and Engineers Open Forum
2012
Development of new drug candidates using novel approaches
2014 The Korean Society of Molecular Imaging
2014
Development of a Histone H1-Specific Aptide as a Novel Apoptotic Imaging Probe and Evaluation for Monitoring Anti-Cancer Drug Responses